M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Cash from Investing Activities Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Cash from Investing Activities
-€440k
CAGR 3-Years
6%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Cash from Investing Activities
€73.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Cash from Investing Activities
-€1.1m
CAGR 3-Years
N/A
CAGR 5-Years
18%
CAGR 10-Years
-7%
Inventiva SA
PAR:IVA
Cash from Investing Activities
-€7.7m
CAGR 3-Years
-40%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Cash from Investing Activities
-€318k
CAGR 3-Years
58%
CAGR 5-Years
29%
CAGR 10-Years
-5%
OSE Immunotherapeutics SA
PAR:OSE
Cash from Investing Activities
-€55.5m
CAGR 3-Years
N/A
CAGR 5-Years
-160%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Cash from Investing Activities?
Cash from Investing Activities
-440k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Cash from Investing Activities amounts to -440k EUR.

What is Maat Pharma SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-7%

Over the last year, the Cash from Investing Activities growth was 46%. The average annual Cash from Investing Activities growth rates for Maat Pharma SA have been 6% over the past three years , -7% over the past five years .

Back to Top